Why Is Breast MRI so Controversial?
暂无分享,去创建一个
[1] C. Balu-Maestro,et al. MRI for the size assessment of pure ductal carcinoma in situ (DCIS): a prospective study of 33 patients. , 2011, European journal of radiology.
[2] E. Morris. Should we dispense with preoperative breast MRI? , 2010, The Lancet.
[3] Andrew Hanby,et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial , 2010, The Lancet.
[4] W. Kaiser,et al. The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer , 2010, Breast Cancer Research and Treatment.
[5] R. Warren,et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Barbara L. Smith,et al. The American Cancer Society guidelines for breast screening with magnetic resonance imaging , 2008, Cancer.
[7] H. Al-Hallaq,et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation , 2008, Cancer.
[8] James W Sayre,et al. National trends and practices in breast MRI. , 2008, AJR. American journal of roentgenology.
[9] Les Irwig,et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Veltman,et al. The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[11] R. Schmidt,et al. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. , 2007, Radiology.
[12] Simone Schrading,et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study , 2007, The Lancet.
[13] Elisabeth G. E. de Vries,et al. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands , 2007, Breast Cancer Research and Treatment.
[14] C. Gatsonis,et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.
[15] G. Kerr,et al. Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience , 2007, British Journal of Cancer.
[16] C. Gatsonis,et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. , 2007, The New England journal of medicine.
[17] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.
[18] Carmel Hayes,et al. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. , 2006, Radiology.
[19] R. Fimmers,et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] N. Hylton,et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) trial , 2005, Journal of surgical oncology.
[21] K. McMahon,et al. Breast magnetic resonance imaging: an essential role in malignant axillary lymphadenopathy of unknown origin. , 2005, Australasian radiology.
[22] Joan Leach,et al. Expert heads a'rolling Melissa Leach Ian , 2005, The Lancet.
[23] L. Esserman,et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. , 2005, AJR. American journal of roentgenology.
[24] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[25] Constantine Gatsonis,et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging , 2005, Cancer.
[26] Rebecca S Lewis,et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.
[27] D. Annane,et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis , 2004, BMJ : British Medical Journal.
[28] H. D. de Koning,et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.
[29] Uwe Fischer,et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer , 2004, European Radiology.
[30] A. D. De Schepper,et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[31] M. El-Tamer,et al. The development of interval breast malignancies in patients with BRCA mutations , 2004, Cancer.
[32] A. D. De Schepper,et al. Preoperative breast MRI in patients with invasive lobular breast cancer , 2004, European Radiology.
[33] Isabelle Bedrosian,et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging , 2003, Cancer.
[34] Mitchell D Schnall,et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. , 2003, Radiology.
[35] D. Schultz,et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] R. Prescott,et al. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[37] J. Satagopan,et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] J. Klijn,et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] S. Weinstein,et al. MR imaging of the breast in patients with invasive lobular carcinoma. , 2001, AJR. American journal of roentgenology.
[40] J. Olson,et al. Magnetic Resonance Imaging Facilitates Breast Conservation for Occult Breast Cancer , 2000, Annals of Surgical Oncology.
[41] S J Schnitt,et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] E Grabbe,et al. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. , 1999, Radiology.
[43] D. Schultz,et al. Role of magnetic resonance imaging and magnetic resonance imaging--guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. , 1999, American journal of clinical oncology.
[44] D. Fraker,et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. , 1999, Radiology.
[45] S. Jeffrey,et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation , 1995, Cancer.
[46] M D Schnall,et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. , 1995, Radiology.
[47] C. Scott-Conner,et al. Axillary metastasis from occult breast carcinoma: diagnosis and management. , 1995, The American surgeon.
[48] M. Osborne,et al. Occult breast cancer presenting with axillary metastases. Updated management. , 1990, Archives of surgery.
[49] Dockerty Mb,et al. Occult carcinoma of the breast. , 1954 .
[50] Jeffrey D Blume,et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. , 2010, Radiology.
[51] P. Bult,et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast , 2009, Breast Cancer Research and Treatment.
[52] J. Overgaard,et al. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[53] S. Singletary,et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy , 2007, Annals of Surgical Oncology.
[54] M. Hirose,et al. Prospective evaluation of pectoralis muscle invasion of breast cancer by MR imaging , 2005, Breast cancer.
[55] M Oudkerk,et al. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. , 2000, AJR. American journal of roentgenology.
[56] L. Schwartz,et al. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. , 2000, Radiology.